Adverum Biotechnologies Inc (ADVM)
9.28
-0.27
(-2.83%)
USD |
NASDAQ |
May 10, 16:00
9.28
0.00 (0.00%)
After-Hours: 19:31
Adverum Biotechnologies Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -807.1% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -379.1% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -6.45K% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -22.37K% |
| September 30, 2018 | -2.52K% |
| Date | Value |
|---|---|
| June 30, 2018 | -3.82K% |
| March 31, 2018 | -7.96K% |
| December 31, 2017 | -3.21K% |
| September 30, 2017 | -2.99K% |
| June 30, 2017 | -2.47K% |
| March 31, 2017 | -3.48K% |
| December 31, 2016 | -4.59K% |
| September 30, 2016 | -3.62K% |
| June 30, 2016 | -20.08K% |
| March 31, 2016 | -5.81K% |
| December 31, 2015 | -1.47K% |
| September 30, 2015 | -1.48K% |
| June 30, 2015 | -4.81K% |
| March 31, 2015 | -4.68K% |
| December 31, 2014 | -5.12K% |
| September 30, 2014 | -4.05K% |
| June 30, 2014 | -3.77K% |
| March 31, 2014 | -5.54K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.45K%
Minimum
Sep 2019
-379.1%
Maximum
Mar 2021
-2.54K%
Average
-807.1%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Karyopharm Therapeutics Inc | -124.0% |
| Ardelyx Inc | -57.62% |
| Minerva Neurosciences Inc | -- |
| Arcutis Biotherapeutics Inc | -490.0% |
| 4D Molecular Therapeutics Inc | -- |